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It's about years that the relation between renin angiotensin aldosterone system (RAS) and involving enzymes 
such as angiotensin converting enzyme (ACE) with nephrotic syndrome is under the focus of researchers and 
also there are a lot of meta-analyses. However there were few studies investigated the relation of ACE 
polymorphism and sensitivity or resistance to steroid therapy in children. So we intend to do that. In the current 
study the sample size was 40 children. Among them, 22 patients were sensitive and 18 patients were resistant to 
steroid therapy. The samples were collected from Ali-Asghar pediatric hospital in Tehran, Iran. We used 
polymerase chain reaction (PCR) for the genotyping. After that, we used Chi-squared test for statistical analysis. 
The statistical analysis showed no significant correlation between ACE polymorphism and sensitivity or 
resistance to steroid therapy (P = 0.77). Although the frequency of DD genotype was higher in the resistant 
group, but this difference was not statistically significant. Finally we found that although based on previous 
studies, D allele and DD genotype are more frequent in children with idiopathic nephrotic syndrome in 
comparison to healthy children, but the resistance or sensitivity to steroid therapy in children is not associated 
with ACE polymorphism. Further meta-analysis on the studies done on children is suggested. 
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INTRODUCTION 
 
It's about years that the relation between renin 
angiotensin aldosterone system (RAS) and involving enzymes 
such as angiotensin converting enzyme (ACE) with nephrotic 
syndrome is under the focus of researchers and also there are a 
lot of meta-analyses (Ai et al., 2016; Cargnin et al., 2015). As an 
introduction, ACE is a renal-pulmonary enzyme which converts 
angiotensin-1 (the inactive form of the enzyme) to angiotensis-2 
(the active form of the enzyme acts as a vasoactive peptide). 
Hence, over expression of ACE could result in higher levels of 
angiotensin-2 that in  turn  
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leads to hemodynamic complications of kidneys (Bernstein et al., 
2016) such as glomerulosclerosis (Beer et al., 2016). Other than 
playing the blood filtering role, kidneys are a part of the endocrine 
system that the RAS is the best example for this fact (Ahmadi, et 
al., 2016; Nasri, 2015). In other words, RAS controls blood 
pressure, volume and electrolyte (Anderson et al., 2016). Other 
than the items above, RAS plays a role in hematopoiesis and other 
physiological processes of human body (Kim et al., 2016). In this 
endocrine system, in response to reduction of electrolyte level, 
blood volume and blood pressure, podocytes – the cells limiting 
plasma passing in glomerulus with help of their foot processes 
surrounding the capillaries and their penetrations to make the 
glomerular barrier (Hajhosieni et al., 2014)-and juxtaglomerular 
apparatus release  the hormone  renin (Nasri, 2015). In blood, renin 
in turn converts the angiotensinogen produced by liver to 
angiotensin-1.  
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In response to reduction of electrolyte, volume and 
pressure of blood, juxtaglomerular apparatus release renin in 
blood. Renin in turn impacts on angiotensinogen in liver and 
converts it to angiotensin I.  
The angiotensin I converts to angiotensin II by the ACE 
presenting and acting in pulmonary circulation. Therefore, hypoxic 
injuries to lungs could results in imbalance of ACE. The 
angiotensin II in turn results in increase of feeling thirsty, 
intestinal salt absorption, aldosterone releasing from adrenal 
glands, maintaining salts and water by kidneys, increasing cardiac 
output, etc. (Gralinski et al., 2016).   
The most famous type of nephrotic syndrome are 
minimal changing, and focal and segmental glomerulosclerosis 
(FSGS) (Inaba et al., 2016). This disease is the most commonplace 
kidney disease in children (Elie et al., 2012; Yildiz et al., 2013). 
The disease is usually primary and sometimes is secondary to 
metabolic, systemic (Lee et al., 2016) or inflectional reasons 
(Chan et al., 2016). Up to now, a lot of involving genes have been 
identified. Outbreak of nephrotic syndrome in Europe and the US 
gets to 16 out of 10000 children (Benoit et al., 2010). This disease 
gets to end-stage in about 10-20% of the patients (Antignac, 2002). 
Relapse of the disease is commonplace and usually occurs 14 days 
after transplantation (Antignac, 2002). Patients with nephrotic 
syndrome are at risk of thrombo-emboli due to hemostatic 
disorders. It seems that crossing of heavy proteins triggers the 
coagulation cascade (Sagripanti and Barsotti, 1995).  
Because of anti-inflammatory effects of the steroids, they 
are used for treatment of nephrotic syndrome in children. 
Individuals with nephrotic syndrome divided into two groups of 
sensitive and resistant to steroid therapy (Braun et al., 2016). 
Among them about 90% are sensitive to steroid therapy (Benoit et 
al., 2010).  
ACE has two allelic forms of insertion (I) and deletion 
(D). It has been proved in a lot of meta-analyses that                
severity of nephrotic syndrome is associated with the genotype DD 
followed by ID (El-Gayar et al., 2015). So we intend to find that 
whether sensitivity or resistance to steroid therapy is associated 
with ACE polymorphism or not.  
 
METHODS 
 
In the current study we used randomized sampling. The 
sample size was 40 children (20 boys and 20 girls). Among them, 
22 patients were sensitive and 18 patients were resistant to steroid 
therapy. The samples were collected from Ali-Asghar pediatric 
hospital in Tehran, Iran. This study had been approved by ethic 
committee of Iran University of Medical Sciences. 
After getting the written consents from the parents of the 
children, we collected blood samples from them. Then we used 
polymerase chain reaction (PCR) for the genotyping. After 
collection of the results from electrophoresis on 1%                          
agarose gel (figure 1), we used Chi-squared test for statistical 
analysis with considering P = 0.05 as the significance level. 
 
 
 
Fig. 1:  The results on the 1% agarose gel. 1) DNA indicator (X174 HaeIII 
cleaved Mr); 2) DD genotype; 3) II genotype; 4) ID genotype. 
 
RESULTS AND DISCUSSION 
 
The statistical analysis showed no significant correlation 
between ACE polymorphism and sensitivity or resistance to 
steroid therapy (figure 2) (P = 0.77). Although the frequency of 
DD genotype was higher in the resistant group, but this difference 
was not statistically significant. The results of our study in Iran, 
shows no significant relation. Ahmed El-Gayar et al. in Egypt 
found that the frequency of DD genotype was higher in steroid 
resistant patients, of course in adults (El-Gayar et al., 2015). In the 
study of Őktem et al done on children, DD genotype was more 
frequent in patients group; but there was no assessment between 
resistant and sensitive patients (Őktem et al., 2004). There were 
just few studies compared ACE polymorphism with resistance or 
sensitivity to steroid therapy that most of them were reanalyzed in 
a meta-analysis done by Zhou et al. (2011). They found that ACE 
polymorphism cannot predict the sensitivity or resistance to steroid 
therapy in children with idiopathic nephrotic syndrome.  
Kidney injuries are serious conditions with serious 
consequences if failed to diagnose on time. Hence, finding 
diagnostic tests for prevention of kidney injuries is necessary 
(Poorshahbaz et al., 2015). As a strategic prevention program for 
low-income countries, governments are supposed to give insight 
and awareness to their people about screening tests (Perico and 
Remuzzi, 2016). However based on the findings of ours and 
previous researchers' the PCR cannot be used for prediction of the 
sensitivity or resistance to steroid therapy, but the PCR test for 
prediction of nephrotic syndrome in children with familial history 
is necessary to take prophylactic measures. 
 
208                                                              Ahmadi et al. / Journal of Applied Pharmaceutical Science 6 (12); 2016: 206-208 
 
 
 
Fig . 2:  The statistical results. 
 
CONCLUSION 
  
Finally we found that although based on previous studies, 
D allele and DD genotype are more frequent in children with 
idiopathic nephrotic syndrome in comparison to healthy children, 
but the resistance or sensitivity to steroid therapy in children is not 
associated with ACE polymorphism. Further meta-analysis on the 
studies done on children is suggested. 
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